Surgical Pathology, National Cancer Institute (Mexico), Tlalpan 14080, Mexico City, Mexico.
AFINES Program, Medicine Faculty, National Autonomus Universiti of Mexico (UNAM), Coyoacán 04510, Mexico City, Mexico.
Medicina (Kaunas). 2024 Jul 24;60(8):1194. doi: 10.3390/medicina60081194.
: Colon cancer (CC) is prevalent globally, constituting 11.9% of cases in Mexico. Lymph node metastases are established prognostic indicators, with extracapsular lymph node extension (ENE) playing a crucial role in modifying prognosis. While ENE is associated with adverse factors, certain aspects, like matted nodes (lymph node conglomerates), are underexplored. Matted nodes, clusters of lymph nodes infiltrated by cancer cells, are recognized as an independent prognostic factor in other cancers. This study investigates the prognostic implications of matted nodes in CC. : From a retrospective analysis of 502 CC consecutive cases treated with colectomy (2005-2018), we identified 255 (50.8%) cases with lymph node metastasis (our study group), which were categorized into two groups: (1) lymph node metastasis alone (n = 208), and (2) lymph node metastasis with matted nodes (n = 47). A comparative survival analysis was performed. : Of the 255 patients, 38% had lymph node metastasis. Patients with matted nodes (18.4%) showed an association with higher pN stage and lymphovascular invasion. The 5-year survival rate for patients with matted nodes was 47.7%, compared to 60% without ( = 0.096); however, this association demonstrated only a statistical tendency. Multivariate analysis identified clinical stage and adjuvant chemotherapy use as independent factors contributing to survival. : This study underscores matted nodes as potential prognostic indicators in CC, emphasizing their association with higher pN stage and reduced survival. Although the patients with matted nodes showed lower survival, this figure did not search statistical significance, but a tendency was detected, which necessitates precise further research, which is essential for validating these findings and integrating matted nodes into the broader context of colorectal cancer management.
: 结直肠癌(CC)在全球范围内普遍存在,在墨西哥占病例的 11.9%。淋巴结转移是既定的预后指标,其中包膜外淋巴结扩展(ENE)在改变预后方面起着关键作用。虽然 ENE 与不良因素有关,但某些方面,如结节融合(淋巴结聚集体),尚未得到充分探索。结节融合是指被癌细胞浸润的淋巴结聚集体,已被认为是其他癌症的独立预后因素。本研究调查了结直肠癌中结节融合的预后意义。 : 我们对 502 例连续接受结肠切除术(2005-2018 年)治疗的 CC 病例进行了回顾性分析,其中 255 例(50.8%)有淋巴结转移(我们的研究组),分为两组:(1)单纯淋巴结转移(n = 208),和(2)淋巴结转移伴结节融合(n = 47)。进行了比较生存分析。 : 在 255 例患者中,38%有淋巴结转移。有结节融合的患者(18.4%)与更高的 pN 分期和淋巴血管侵犯有关。有结节融合的患者 5 年生存率为 47.7%,而无结节融合的患者为 60%(= 0.096);然而,这种关联仅表现出统计学趋势。多变量分析确定临床分期和辅助化疗的使用是生存的独立因素。 : 本研究强调了结节融合作为 CC 的潜在预后指标,突出了它们与更高的 pN 分期和降低的生存率相关。尽管有结节融合的患者生存率较低,但这一数字没有达到统计学意义,但检测到了一种趋势,这需要进行更精确的进一步研究,这对于验证这些发现并将结节融合纳入结直肠癌管理的更广泛背景至关重要。